CA-125 monitoring in ovarian cancer: patient survey responses to the results of the MRC/EORTC CA-125 Surveillance Trial

Oncology. 2010;78(1):1-2. doi: 10.1159/000292352. Epub 2010 Mar 6.

Authors

Maurie Markman, Judith Petersen, Angela Belland, Kenda Burg

PMID: 20215782
DOI: 10.1159/000292352

No abstract available

Publication types

Editorial

MeSH terms

Biomarkers, Tumor / blood*
CA-125 Antigen / blood*
Female
Health Care Surveys
Humans
Ovarian Neoplasms / blood*
Ovarian Neoplasms / diagnosis*
Randomized Controlled Trials as Topic

Substances

Biomarkers, Tumor
CA-125 Antigen